← Back to Clinical Trials
Recruiting NCT06401057

NCT06401057 Register for Longitudinal Recording of Brain Function

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06401057
Status Recruiting
Phase
Sponsor University Hospital Heidelberg
Condition Patients With Brain Masses/Lesions
Study Type OBSERVATIONAL
Enrollment 1,000 participants
Start Date 2024-01-01
Primary Completion 2025-01-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 1,000 participants in total. It began in 2024-01-01 with a primary completion date of 2025-01-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this observational register study is to establish a registry that completely records and compiles the data from routinely performed technical examinations (navigated transcranial magnetic stimulation, intraoperative neuromonitoring and stimulation, MRI imaging including tractography and connectome) and clinical tests over time (pre-, intra- and postoperative, under adjuvant therapy, as part of follow-up care) of patients with intracranial masses and lesions.

Eligibility Criteria

Inclusion Criteria: * Intracranial lesion * Age ≥ 18 years * Written consent to participate in the study Exclusion Criteria: * Age \< 18 years * Patients not able to give consent * Patients with intracranial ferromagnetic metal implants * Patients with implanted electronic devices

Frequently Asked Questions

Who can join the NCT06401057 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Patients With Brain Masses/Lesions. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06401057 currently recruiting?

Yes, NCT06401057 is actively recruiting participants. Visit ClinicalTrials.gov or contact University Hospital Heidelberg to inquire about joining.

Where is the NCT06401057 trial being conducted?

This trial is being conducted at Heidelberg, Germany.

Who is sponsoring the NCT06401057 clinical trial?

NCT06401057 is sponsored by University Hospital Heidelberg. The trial plans to enroll 1,000 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology